Wellington Management Group
BBOT

Wellington Management Group’s BridgeBio Oncology BBOT Stock Holding History

Wellington Management Group’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.2M Sell
2,818,348
-88,655
-3% -$952K ﹤0.01% 924
2025
Q4 		$36.4M Sell
2,907,003
-54,260
-2% -$657K 0.01% 827
2025
Q3 		$34.3M Buy
2,961,263
+2,776,673
+1,504% +$28.9M 0.01% 838
2025
Q2 		$1.97M Hold
184,590
– – ﹤0.01% 1585
2025
Q1 		$2.09M Hold
184,590
– – ﹤0.01% 1550
2024
Q4 		$1.94M Sell
184,590
-80
-0% -$842 ﹤0.01% 1571
2024
Q3 		$1.93M Hold
184,670
– – ﹤0.01% 1548
2024
Q2 		$1.89M Sell
184,670
-17,490
-9% -$180K ﹤0.01% 1531
2024
Q1 		$2.09M Buy
+202,160
New +$2.09M ﹤0.01% 1512

Other funds holding BBOT

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Wellington Management Group's BBOT Position: Q1 2026 in Review

Wellington Management Group reduced its BridgeBio Oncology (BBOT) stake by 3% in Q1 2026, selling an estimated $952K and leaving 2,818,348 shares worth $25.2M. The position accounts for ﹤0.01% of the portfolio, ranked #924.

Wellington Management Group first reported a position in BBOT in Q1 2024 and has held it in 9 quarters since. The position peaked at $36.4M in Q4 2025. 67 funds tracked by Wall St. Rank hold BBOT as of Q1 2026.

  • Wellington Management Group held 2,818,348 shares of BridgeBio Oncology worth $25.2M as of Q1 2026.
  • Wellington Management Group sold 88,655 BridgeBio Oncology shares in Q1 2026, an estimated $952K.
  • BridgeBio Oncology made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #924 holding.
  • Wellington Management Group first reported a position in BridgeBio Oncology in Q1 2024 and has held it in 9 quarters since.
  • Wellington Management Group's BridgeBio Oncology position peaked at $36.4M in Q4 2025.
  • 67 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.